| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 21 |
| 1 | ASPIRIN 325 MG | 20 |
| 2 | ASPIRIN 81 MG | 20 |
| 3 | CLOPIDOGREL | 17 |
| 4 | RIVAROXABAN | 17 |
| 5 | CLOPIDOGREL BISULFATE | 13 |
| 6 | FUROSEMIDE | 10 |
| 7 | LISINOPRIL | 9 |
| 8 | PREDNISONE | 9 |
| 9 | AMLODIPINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 2 | 0.0057 |
| 1 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 2 | 0.0052 |
| 2 | TOLCAPONE | 1 | 0.0028 |
| 3 | LEVOCARNITINE | 5 | 0.0014 |
| 4 | COAL TAR | 1 | 0.0013 |
| 5 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 6 | IDARUCIZUMAB | 1 | 0.0007 |
| 7 | AMIFAMPRIDINE PHOSPHATE | 2 | 0.0007 |
| 8 | ARGATROBAN | 1 | 0.0007 |
| 9 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 21 |
| 3 | Factor Xa Inhibitor [EPC] | 18 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 12 |
| 5 | beta-Adrenergic Blocker [EPC] | 11 |
| 6 | Loop Diuretic [EPC] | 10 |
| 7 | Benzodiazepine [EPC] | 9 |
| 8 | Calcium Channel Blocker [EPC] | 8 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 5 | 0.0014 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 6 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 8 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 12 | 0.0001 |